These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38267373)

  • 1. Nanomaterials-Based Targeting of Long Non-Coding RNAs in Cancer: A Cutting-Edge Review of Current Trends.
    Davodabadi F; Farasati Far B; Sargazi S; Fatemeh Sajjadi S; Fathi-Karkan S; Mirinejad S; Ghotekar S; Sargazi S; Rahman MM
    ChemMedChem; 2024 Apr; 19(8):e202300528. PubMed ID: 38267373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNAs: From disease code to drug role.
    Chen Y; Li Z; Chen X; Zhang S
    Acta Pharm Sin B; 2021 Feb; 11(2):340-354. PubMed ID: 33643816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting long non-coding RNAs in cancers: progress and prospects.
    Li CH; Chen Y
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State of the art technologies to explore long non-coding RNAs in cancer.
    Salehi S; Taheri MN; Azarpira N; Zare A; Behzad-Behbahani A
    J Cell Mol Med; 2017 Dec; 21(12):3120-3140. PubMed ID: 28631377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotherapeutic approaches for delivery of long non-coding RNAs: an updated review with emphasis on cancer.
    Davodabadi F; Mirinejad S; Malik S; Dhasmana A; Ulucan-Karnak F; Sargazi S; Sargazi S; Fathi-Karkan S; Rahdar A
    Nanoscale; 2024 Feb; 16(8):3881-3914. PubMed ID: 38353296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hacking the Cancer Genome: Profiling Therapeutically Actionable Long Non-coding RNAs Using CRISPR-Cas9 Screening.
    Esposito R; Bosch N; Lanzós A; Polidori T; Pulido-Quetglas C; Johnson R
    Cancer Cell; 2019 Apr; 35(4):545-557. PubMed ID: 30827888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting long non-coding RNAs in cancer therapy using CRISPR-Cas9 technology: A novel paradigm for precision oncology.
    Mahato RK; Bhattacharya S; Khullar N; Sidhu IS; Reddy PH; Bhatti GK; Bhatti JS
    J Biotechnol; 2024 Jan; 379():98-119. PubMed ID: 38065367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs in hematological malignancies: translating basic techniques into diagnostic and therapeutic strategies.
    Wong NK; Huang CL; Islam R; Yip SP
    J Hematol Oncol; 2018 Nov; 11(1):131. PubMed ID: 30466456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
    Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
    Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA implicated in the invasion and metastasis of head and neck cancer: possible function and mechanisms.
    Luo X; Qiu Y; Jiang Y; Chen F; Jiang L; Zhou Y; Dan H; Zeng X; Lei YL; Chen Q
    Mol Cancer; 2018 Jan; 17(1):14. PubMed ID: 29368602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Genome-Wide CRISPR Activation Screening Identifies Functionally Important Long Noncoding RNAs in Hepatocellular Carcinoma.
    Wong LS; Wei L; Wang G; Law CT; Tsang FH; Chin WC; Ng IO; Wong CM
    Cell Mol Gastroenterol Hepatol; 2022; 14(5):1053-1076. PubMed ID: 35944892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNAs as Architects in Cancer Biomarkers with Interface of Epitranscriptomics- Incipient Targets in Cancer Therapy.
    Ray SK; Mukherjee S
    Curr Cancer Drug Targets; 2021; 21(5):416-427. PubMed ID: 33413062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies.
    Zhang F; Zhang L; Zhang C
    Tumour Biol; 2016 Jan; 37(1):163-75. PubMed ID: 26586396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.
    Chandra Gupta S; Nandan Tripathi Y
    Int J Cancer; 2017 May; 140(9):1955-1967. PubMed ID: 27925173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides.
    Lennox KA; Behlke MA
    Nucleic Acids Res; 2016 Jan; 44(2):863-77. PubMed ID: 26578588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village.
    Ao YQ; Gao J; Jiang JH; Wang HK; Wang S; Ding JY
    Mol Ther; 2023 Dec; 31(12):3389-3413. PubMed ID: 37740493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs in cancer and development: where do we go from here?
    Haemmerle M; Gutschner T
    Int J Mol Sci; 2015 Jan; 16(1):1395-405. PubMed ID: 25580533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNAs as the regulators and targets of macrophage M2 polarization.
    Dong R; Zhang B; Tan B; Lin N
    Life Sci; 2021 Feb; 266():118895. PubMed ID: 33310042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the therapeutic potential of quercetin in cancer treatment: Targeting long non-coding RNAs.
    Sheikhnia F; Fazilat A; Rashidi V; Azizzadeh B; Mohammadi M; Maghsoudi H; Majidinia M
    Pathol Res Pract; 2024 Aug; 260():155374. PubMed ID: 38889494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.